This is an AMP page which is for mobile devices.
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Shares of the clinical-stage cell therapy company Adaptimmune Therapeutics (NASDAQ: ADAP) were down by 9.1% as of 2:37 p.m. ET on Wednesday. Earlier today, the biotech's shares were down by an unsightly 12.5% at their low point.
Investors appear to be throwing in the towel on Adaptimmune stock today for three reasons:
Image source: Getty Images.
For further details see:
Why Adaptimmune Therapeutics Stock Is Crashing Today| Company Name: | Adaptimmune Therapeutics plc |
| Stock Symbol: | ADAP |
| Market: | NASDAQ |
| Website: | adaptimmune.com |
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.